These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15806172)

  • 41. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
    Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT
    Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy.
    Mayhew CN; Bosco EE; Fox SR; Okaya T; Tarapore P; Schwemberger SJ; Babcock GF; Lentsch AB; Fukasawa K; Knudsen ES
    Cancer Res; 2005 Jun; 65(11):4568-77. PubMed ID: 15930274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MCM4 shares homology to a replication/DNA-binding domain in CTF and is contacted by pRb.
    Schmitz NM; Leibundgut K; Hirt A
    Biochem Biophys Res Commun; 2004 May; 317(3):779-86. PubMed ID: 15081408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
    Patrick DR; Oliff A; Heimbrook DC
    J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor.
    Liu X; Marmorstein R
    Genes Dev; 2007 Nov; 21(21):2711-6. PubMed ID: 17974914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of DNA binding of Sox2 by the SUMO conjugation.
    Tsuruzoe S; Ishihara K; Uchimura Y; Watanabe S; Sekita Y; Aoto T; Saitoh H; Yuasa Y; Niwa H; Kawasuji M; Baba H; Nakao M
    Biochem Biophys Res Commun; 2006 Dec; 351(4):920-6. PubMed ID: 17097055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of the cell cycle by viral oncoproteins.
    Vousden KH
    Semin Cancer Biol; 1995 Apr; 6(2):109-16. PubMed ID: 7647307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular dynamics simulations of retinoblastoma protein.
    Ramakrishnan C; Subramanian V; Balamurugan K; Velmurugan D
    J Biomol Struct Dyn; 2013; 31(11):1277-92. PubMed ID: 23157310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1).
    Budde A; Schneiderhan-Marra N; Petersen G; Brüne B
    Oncogene; 2005 Mar; 24(10):1802-8. PubMed ID: 15674338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
    Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
    J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.
    Gostissa M; Hengstermann A; Fogal V; Sandy P; Schwarz SE; Scheffner M; Del Sal G
    EMBO J; 1999 Nov; 18(22):6462-71. PubMed ID: 10562558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
    Chen A; Wang PY; Yang YC; Huang YH; Yeh JJ; Chou YH; Cheng JT; Hong YR; Li SS
    J Cell Biochem; 2006 Jul; 98(4):895-911. PubMed ID: 16475184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosis.
    Babic I; Cherry E; Fujita DJ
    Oncogene; 2006 Aug; 25(36):4955-64. PubMed ID: 16568089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LxCxD motif of the APC/C coactivator subunit FZR1 is critical for interaction with the retinoblastoma protein.
    Ramanujan A; Bansal S; Guha M; Pande NT; Tiwari S
    Exp Cell Res; 2021 Jul; 404(2):112632. PubMed ID: 33971196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SUMO: a regulator of gene expression and genome integrity.
    Müller S; Ledl A; Schmidt D
    Oncogene; 2004 Mar; 23(11):1998-2008. PubMed ID: 15021887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.
    Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC
    Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenovirus E1A targets key regulators of cell proliferation.
    Dyson N; Harlow E
    Cancer Surv; 1992; 12():161-95. PubMed ID: 1353412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.